Add-on pramipexole for anhedonic depression: study protocol for a randomised controlled trial and open-label follow-up in Lund, Sweden
Introduction Many depressed patients do not achieve remission with available treatments. Anhedonia is a common residual symptom associated with treatment resistance as well as low function and quality of life. There are currently no specific and effective treatments for anhedonia. Some trials have s...
Main Authors: | Moa Eklund, Jesper Lindahl, Marie Asp, Darya Ståhl, Johanna Tjernberg, Johannes Björkstrand, Danielle van Westen, Jimmy Jensen, Kristoffer Månsson, Åsa Tornberg, Martina Svensson, Tomas Deierborg, Filip Ventorp, Daniel Lindqvist |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/11/e076900.full |
Similar Items
-
Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic Depression
by: Filip Ventorp, et al.
Published: (2022-06-01) -
Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT
by: Ludovic Christophe Dormegny-Jeanjean, et al.
Published: (2023-09-01) -
Sucrose Preference Test to Measure Anhedonic Behaviour in Mice
by: Tsvetan Serchov, et al.
Published: (2016-10-01) -
Vortioxetine ameliorates anhedonic-like behaviour and promotes strategic cognitive performance in a rodent touchscreen task
by: Lena-Sophie Martis, et al.
Published: (2021-04-01) -
The Sweet Drive Test: Refining phenotypic characterization of anhedonic behavior in rodents
by: António eMateus-Pinheiro, et al.
Published: (2014-03-01)